Understanding CMS's New COPD Coverage: What HME Providers Need to Know

Published in Member Communities on July 02, 2025

Ronda BuhrmesterBy Ronda Buhrmester, Sr. Director of Payer Relations and Reimbursement, VGM & Associates

On June 9, 2025, CMS released the implications of the newly finalized National Coverage Determination (NCD) for home mechanical ventilation (HMV) and respiratory assist devices (RAD). While the final NCD has an effective date of June 9, 2025, implementation instructions are yet to come!

The final NCD introduces expanded coverage for RADs and HMVs for patients with chronic respiratory failure due to COPD.

Key changes include: 

  • Clearer Initial and Continuing Coverage Criteria: CMS now outlines specific PaCO₂ with an arterial blood gas (ABG) and continued usage metrics for both RADs and HMVs. 
  • Compliance Demands: New documentation, usage tracking, and patient re-evaluation requirements will increase operational oversight—without added reimbursement. 
  • Hospital Discharge Provisions: Immediate post-discharge coverage is available for patients meeting defined clinical criteria. 
  • Grandfathering: Existing patients on HMV and RADs for COPD are grandfathered in.  
  • MAC Discretion: For cases outside the NCD scope, the DME Medicare Administrative Contractors (DME MACs) retain authority to determine coverage. 

Emphasis needs to be on the importance of proactive education and compliance monitoring with referral sources, staff, and patients. Suppliers are encouraged to prepare for increased documentation demands, patient re-evaluations, and tighter monitoring—without additional reimbursement. 

As the industry awaits further CMS instructions, one message was clear: educate, adapt, and stay ahead. 

We recently held a webinar with myself and industry experts Kim Cuce’, Noel Neil, and Zach Gantt about the key changes of this decision, the operational and financial impact on DME suppliers, and actionable strategies to navigate the new landscape. Click here to view the recording

For any questions, please reach out to me at ronda.buhrmester@vgm.com


TAGS

  1. billing & reimbursement
  2. cms
  3. oxygen
  4. reimbursement
  5. respiratory

From Our Experts

Why Signature Issues Continue to Trip Up DME Suppliers thumbnail Why Signature Issues Continue to Trip Up DME Suppliers Discover why signature-related documentation issues continue to create claim denials, audit risks, and reimbursement challenges for DME suppliers. The Fortune Is in the Follow-Up thumbnail The Fortune Is in the Follow-Up The fortune is in the follow-up. Not because follow-up is exciting. Most of the time it's not. In fact, it's often the least glamorous part of the job. But that's exactly why it creates so much value. Most people are willing to start something. Fewer people are willing to stick with it until it's finished. Optimize Your Sleep Therapy Program: A Scalable, Patient-Centered Blueprint for HME Providers thumbnail Optimize Your Sleep Therapy Program: A Scalable, Patient-Centered Blueprint for HME Providers Discover how to optimize your sleep therapy business with scalable workflows, faster therapy starts, improved adherence, and predictable revenue growth. Optimize Your Sleep Therapy Program: A Scalable, Patient-Centered Blueprint for HME Providers thumbnail Optimize Your Sleep Therapy Program: A Scalable, Patient-Centered Blueprint for HME Providers Discover how to optimize your sleep therapy business with scalable workflows, faster therapy starts, improved adherence, and predictable revenue growth. Adaptability Is Key to Long-Term Success in HME thumbnail Adaptability Is Key to Long-Term Success in HME Industry leader Lisa Wells shares insights on growth, payer relationships, and AI and why providers must adapt to succeed. ROI of D.C.: Understanding the Impact of CRT and HME Advocacy thumbnail ROI of D.C.: Understanding the Impact of CRT and HME Advocacy Legislation influences patient care. Learn about the importance of voting records in sustaining the CRT and HME industries. The Future of CRT Depends on Stronger Grassroots Advocacy Now thumbnail The Future of CRT Depends on Stronger Grassroots Advocacy Now The future of CRT access depends on broader industry and grassroots advocacy to defend reimbursement, influence policy, and improve patient access to care. Unlearning Is Harder Than Learning—Especially in Billing & Reimbursement thumbnail Unlearning Is Harder Than Learning—Especially in Billing & Reimbursement Outdated billing & reimbursement habits can increase audit risk. Learn why DME suppliers must unlearn assumptions, validate guidance, & strengthen compliance.